Voyageur Pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF) announced that it has successfully completed the environmental and geotechnical field work at its Frances Creek project site in British Columbia.
The company said the milestone represents a significant achievement for Voyageur Pharmaceuticals and its 100% owned Voyageur Industrial Minerals Ltd subsidiary, as it fulfills both the exploration notice of work for barite sampling from the surface vein and paves the way for future quarry permitting.
Voyageur also noted that the detailed site assessment encompassed a comprehensive evaluation of existing baseline conditions within and surrounding the site, while also involving meticulous collection of soil and rock samples along with a thorough review of the current and potential site access road.
The company added that the data, samples, and road assessment gathered during the process will serve as crucial inputs for various planning aspects, including site soil handling and reclamation, invasive weed management practices, acid rock drainage/metal leaching potential, process area planning, and safe access road options.
All activities at Frances Creek have been carried out in strict compliance with rigorous environmental standards, and the findings and outcomes of the field work will be promptly submitted to the BC Ministry of Mines, Voyageur said.
Voyageur Pharmaceuticals is focused on the development of barium and iodine Active Pharmaceutical Ingredients and high-performance, cost-effective imaging contrast agents for the medical imaging marketplace.
Contact Sean at sean@proactiveinvestors.com